Axillary Clearance Following Positive Sentinel Lymph Node Biopsy in Symptomatic Breast Cancer
Open Access
- 3 November 2020
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 34 (6) , 3503-3509
Abstract
Background/Aim: Symptomatic cancers display a different biological behaviour from screen-detected cancers, which may impact the management of axillary metastases. We aimed to determine the role of unselected axillary nodal clearance (ANC) in symptomatic patients with positive sentinel node biopsies (SNBs). Patients and Methods: A case-note review was performed on 95 symptomatic breast cancer patients who underwent ANC following positive SNB. Results: Thirty-eight (40%) patients were treated with a mastectomy and 57 (60%) with breast-conserving surgery. At ANC, 25 patients (26.3%) showed evidence of further lymph node metastases, with 15 (60%) having two or fewer macrometastases. The presence of more than 2 SNB macrometastases was associated with further ANC metastases (p<0.001). The presence of further metastases at ANC was not associated with either reduced overall survival or disease-free survival. Conclusion: A number of symptomatic breast cancer patients with positive SNBs may be overtreated. Ongoing trials examining the management of low volume SNB macrometastases need to consider the symptomatic subgroup in their conclusions.Keywords
This publication has 26 references indexed in Scilit:
- Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key TrialsClinical Breast Cancer, 2018
- Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast CancerJAMA Oncology, 2018
- Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patientsBreast Cancer Research and Treatment, 2017
- Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancerEuropean Journal of Surgical Oncology, 2017
- POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with MacrometastasesClinical Oncology, 2015
- Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) – ACOSOG Z0011 results and beyondThe Breast, 2013
- Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institutionEuropean Journal of Surgical Oncology, 2013
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel nodeThe Breast, 2004
- Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancerThe Breast, 2004